BBM

Philippines Construction Industry Report 2023: Market to Expand by 8.5% in 2023, Followed by 7% in 2024 Supported by Transport and Energy and Affordable Housing Projects - Forecast to 2027 - ResearchAndMarkets.com

Retrieved on: 
Monday, January 29, 2024

Construction industry in the Philippines to expand by 8.5% in 2023, supported by the government's focus on the development of the infrastructure and energy sectors.

Key Points: 
  • Construction industry in the Philippines to expand by 8.5% in 2023, supported by the government's focus on the development of the infrastructure and energy sectors.
  • The publisher expects the construction industry in the Philippines to register an annual average growth rate of 7.1% between 2025 and 2027, supported by the government's focus on the development of transport and energy infrastructure, and affordable housing.
  • Historical (2018-2022) and forecast (2023-2027) valuations of the construction industry in the Philippines, featuring details of key growth drivers.
  • Analysis of the mega-project pipeline, including breakdowns by development stage across all sectors, and projected spending on projects in the existing pipeline.

Dr. Rachel Brem joins Breathe BioMedical as Executive Director and Chief Medical Officer

Retrieved on: 
Tuesday, January 9, 2024

MONCTON, NB, Jan. 9, 2024 /PRNewswire/ - Breathe BioMedical (BBM) is pleased to announce the appointment of Dr. Rachel Brem to the company's Board of Directors in her newly appointed role of Executive Director and Chief Medical Officer.

Key Points: 
  • MONCTON, NB, Jan. 9, 2024 /PRNewswire/ - Breathe BioMedical (BBM) is pleased to announce the appointment of Dr. Rachel Brem to the company's Board of Directors in her newly appointed role of Executive Director and Chief Medical Officer.
  • Dr. Brem is a world-renowned expert in breast cancer and the Director of the Breast Imaging and Interventional Center at the George Washington University.
  • Dr. Brem is the Chief Medical Officer of the Brem Foundation, a 501(c) 3 which began nearly 20 years ago, inspired by her mission and life story that is dedicated to the early detection of breast cancer.
  • "We are excited to have Dr. Brem's leadership at the Executive Director level to lead our Clinical and Regulatory strategy as our Chief Medical Officer."

Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement

Retrieved on: 
Friday, December 29, 2023

The net proceeds from the sale of the Common Shares will be used to repay existing debt and for general corporate and working capital purposes.

Key Points: 
  • The net proceeds from the sale of the Common Shares will be used to repay existing debt and for general corporate and working capital purposes.
  • The Offering was led by Terraflos Inc. (“Terraflos”), a company with operations throughout Latin America founded and controlled by Facundo Garreton (“Mr.
  • Garreton”), who serves as the Chairman, CEO, and a director of Blueberries.
  • Terraflos is currently exploring various prospects in Argentina, Mexico, and Brazil and aims to expand its operations into those markets in the short term.

Blueberries Medical Announces C$2 Million Non-Brokered Private Placement

Retrieved on: 
Friday, December 15, 2023

Terraflos is currently exploring various prospects in Argentina, Mexico, and Brazil and aims to expand its operations into those markets in the short term.

Key Points: 
  • Terraflos is currently exploring various prospects in Argentina, Mexico, and Brazil and aims to expand its operations into those markets in the short term.
  • These funds will be allocated to the full repayment of the last remaining convertible debt, bringing the company to a debt-free position.
  • This venture signifies a milestone not only operationally but also commercially, as it constitutes the largest individual order to date.
  • As a result of this partnership both companies will launch their very first product together during Q2-2024.

Baozun Announces Third Quarter 2023 Unaudited Financial Results

Retrieved on: 
Wednesday, November 22, 2023

SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler in China, today announced its unaudited financial results for the third quarter ended September 30, 2023.

Key Points: 
  • SHANGHAI, Nov. 22, 2023 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler in China, today announced its unaudited financial results for the third quarter ended September 30, 2023.
  • Mr. Vincent Qiu, Chairman and Chief Executive Officer of Baozun, stated, "I am pleased that Baozun Group is collectively demonstrating significant progress in our transformation efforts.
  • This marks the first third quarter since our IPO that Baozun achieved positive operating cash flow, largely driven by business optimization, cost reduction, and improved working capital efficiency.
  • Gross profit margin of product sales for BBM in the third quarter of 2023 was 55.5%, further improved from previous quarters.

Toshiba Launches 30V N-Channel Common-Drain MOSFET Suitable for Devices with USB and for Protecting Battery Packs

Retrieved on: 
Tuesday, November 7, 2023

Toshiba Electronic Devices & Storage Corporation ("Toshiba") has launched “ SSM10N961L ,” a low on-resistance, 30V N-channel common-drain MOSFET, suitable for devices with USB and for protecting battery packs.

Key Points: 
  • Toshiba Electronic Devices & Storage Corporation ("Toshiba") has launched “ SSM10N961L ,” a low on-resistance, 30V N-channel common-drain MOSFET, suitable for devices with USB and for protecting battery packs.
  • View the full release here: https://www.businesswire.com/news/home/20231106160986/en/
    Toshiba: SSM10N961L, a 30V N-channel common-drain MOSFET in a new, small, thin package.
  • (Graphic: Business Wire)
    Until now, Toshiba’s line-up of N-channel common-drain MOSFETs has focused on 12V products, mainly for use in protecting the lithium-ion battery packs of smartphones.
  • The new product is an N-channel common-drain MOSFET that supports bi-directional power supply, and that has a small mounting area.

Amidst an industry ripe for transformation, a new consultancy launches

Retrieved on: 
Tuesday, October 3, 2023

“The digital transformation coming to the professional services industry is long overdue,” says Peter Wright, Ollion’s CEO.

Key Points: 
  • “The digital transformation coming to the professional services industry is long overdue,” says Peter Wright, Ollion’s CEO.
  • “No one wants a 100-page strategy document dropped on their desk anymore – businesses want a partner who is accountable for outcomes.
  • What Ollion understands, and where the many consulting firms struggle for relevance, is that the customer has much more agency in the modern world.
  • How else can enterprises keep up with the speed of newer competitors?”
    “That creates opportunities for new players.

Breathe BioMedical Announces Bill Dawes as CEO

Retrieved on: 
Tuesday, September 5, 2023

MONCTON, NB, Sept. 5, 2023 /PRNewswire/ - Breathe BioMedical (BBM) has announced Bill Dawes as their new Chief Executive Officer (CEO), effective August 14, 2023.

Key Points: 
  • MONCTON, NB, Sept. 5, 2023 /PRNewswire/ - Breathe BioMedical (BBM) has announced Bill Dawes as their new Chief Executive Officer (CEO), effective August 14, 2023.
  • Bill has served as the Chief Business Officer (CBO) at BBM over the last two years before stepping into the role of CEO this week.
  • Bill is an experienced leader in the pharma and diagnostics space, having held executive level positions at Bristol-Myers Squibb, Lantheus Medical Imaging and LikeMinds.
  • In addition to this exciting announcement, Breathe BioMedical has welcomed Dr. Norman Betts to its Board of Directors.

Baozun Announces Second Quarter 2023 Unaudited Financial Results

Retrieved on: 
Monday, August 28, 2023

SHANGHAI, Aug. 28, 2023 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler in China, today announced its unaudited financial results for the second quarter ended June 30, 2023.

Key Points: 
  • SHANGHAI, Aug. 28, 2023 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler in China, today announced its unaudited financial results for the second quarter ended June 30, 2023.
  • Mr. Arthur Yu, Chief Financial Officer of Baozun and President of BEC, commented, "In the second quarter of 2023, BEC once again achieved better year-over-year profits and cash flows, benefiting from our consistent efforts in enhancing value and reducing costs.
  • Currently, BBM mainly comprises product sales revenue of Gap Shanghai, and product sales for BBM in the second quarter of 2023 totaled RMB324.2 million.
  • Gross profit margin of product sales for BBM in the second quarter of 2023 was 51.9%.

Baozun Announces First Quarter 2023 Unaudited Financial Results

Retrieved on: 
Thursday, May 25, 2023

Sales and marketing expenses were RMB592.7 million (US$86.3 million), compared with RMB615.9 million in the same quarter of last year.

Key Points: 
  • Sales and marketing expenses were RMB592.7 million (US$86.3 million), compared with RMB615.9 million in the same quarter of last year.
  • Technology and content expenses were RMB114.9 million (US$16.7 million), compared with RMB105.3 million in the same quarter of last year.
  • The increase was primarily due to an incremental expense related to Gap Shanghai, a subsidiary the Company acquired in the first quarter of 2023.
  • Non-GAAP net loss attributable to ordinary shareholders of Baozun Inc. was RMB13.1 million (US$1.9 million), compared with non-GAAP net income attributable to ordinary shareholders of Baozun Inc. RMB1.2 million in the same quarter of last year.